| Title | Research Area | Implementing Organisations | Funding Organisations | Start Year | Status |
|---|---|---|---|---|---|
| Generation of virus-neutralising human monoclonal antibodies (hmABs) against SARS-CoV-2 as potential therapeutics (CSIR-NMITLI funded project) | Life Sciences & Biotechnology | National Centre for Cell Science (NCCS), Pune | Department of Biotechnology (DBT) | 2020 | — |
| An easy method for developing fusion enabled SARS-CoV-2 virus fusion mimic (SCFM), by passing the need for biosafety level (BSL) facility | Life Sciences & Biotechnology | National Institute of Animal Biotechnology (NIAB) | Department of Biotechnology (DBT) | 2020 | Completed |
| A rapid approach to generate immortalised B cells for monoclonal antibody generation from SARS-CoV-2 recovered and vaccinated group | Life Sciences & Biotechnology | Rajiv Gandhi Centre for Biotechnology (RGCB) | Department of Biotechnology (DBT) | 2020 | — |
| A platform for producing COVID-19 related antigens and antiviral proteins through transient expression in plants | Life Sciences & Biotechnology | National Institute of Plant Genome Research (NIPGR) | Department of Biotechnology (DBT) | 2020 | — |
| Genome sequencing of SARS-CoV-2 from clinical samples | Life Sciences & Biotechnology | National Centre for Cell Science (NCCS), Pune | Department of Biotechnology (DBT) | 2020 | — |
| A novel method to evaluate the quality of antigen-specific T cells in infection and vaccination | Life Sciences & Biotechnology | National Institute of Immunology (NII) | Department of Biotechnology (DBT) | 2020 | Completed |
| Peptide derived synthetic scaffold proteins targeting SARS-COV2 entry into host cells | Life Sciences & Biotechnology | Institute for Stem Cell Science and Regenerative Medicine (inStem) | Department of Biotechnology (DBT) | 2020 | — |
| Human monoclonal antibodies against SARS-CoV-2 | Life Sciences & Biotechnology | International Centre For Genetic Engineering and Biotechnology (ICGEB), New Delhi | Department of Biotechnology (DBT) | 2020 | — |
| Testing potential of glucosinolate derived isothiocyanate for antiviral activity against COVID-19 | Life Sciences & Biotechnology | National Institute of Plant Genome Research (NIPGR) | Department of Biotechnology (DBT) | 2020 | — |
| Pan India 1000 SARS-C0V-2 genomic consortium | Life Sciences & Biotechnology | National Institute of Biomedical Genomics (NIBMG) | Department of Biotechnology (DBT) | 2020 | Completed |
Accessibility Controls